A study co-authored by Northwestern Medicine scientist Rintaro Hashizume, MD, PhD, identified the EAG2 potassium channel as a target for treating medulloblastoma.
Menu
Browsing: Neurology and Neuroscience
Northwestern Medicine scientists have found evidence that a protein that has a genetic link to ALS and other neurodegenerative diseases destroys mitochondria in neurons.
Northwestern Medicine scientist Jeffrey Savas, PhD, and colleagues identified a receptor that sorts proteins in synapses, a finding that may augment future treatments for multiple neurological diseases and disorders.
Northwestern Medicine scientists have discovered for the first time the neurotransmitter pathways that allow stressful fear-related memories become consciously inaccessible.
A clinical study led by Northwestern Medicine scientist Tanya Simuni, MD, crossed a promising compound off the list of potential agents that may slow the progression of Parkinson’s disease.
Music training, introduced as late as high school, may help improve the teenage brain’s responses to sound and sharpen hearing and language skills.
A study showed that an investigational drug, idarucizumab, reverses the anticoagulant effect of dabigatran, a blood thinning drug used for the prevention of stroke. This is the first test of this reversal agent in patients with bleeding or need for emergent surgery.
Studying patients with a rare form of dementia called primary progressive aphasia has given scientists a new understanding of the way the brain comprehends language.
Northwestern Medicine’s Institute for Translational Neuroscience has launched an epilepsy research center, bringing together the academic medical center’s top clinical and research minds in the area of epilepsy.
Enrollees in Feinberg’s Master of Science in Clinical Investigation (MSCI) program developed research projects including a yoga intervention for patients with Parkinson’s disease and a cardiovascular risk assessment for cholesterol guidelines.